Spots Global Cancer Trial Database for cyclophosphamide (cy)
Every month we try and update this database with for cyclophosphamide (cy) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| BuCY vs TBICY Conditioning Regimen for Standard-risk ALL Undergoing Allo-HSCT | NCT02670252 | Allogeneic Hema... Busulfan Total Body Irra... Acute Lymphocyt... | Busulfan (BU) Cyclophosphamid... Total Body Irra... | 14 Years - 65 Years | Nanfang Hospital, Southern Medical University | |
| Decitabine + BUCY vs BUCY Conditioning Regimen for Myeloid Tumors Undergoing Allo-HSCT | NCT04098653 | Allogeneic Hema... Conditioning Myeloid Tumors | Decitabine Busulfan (BU) Cyclophosphamid... | 14 Years - 65 Years | Nanfang Hospital, Southern Medical University | |
| Decitabine + BUCY vs BUCY Conditioning Regimen for Myeloid Tumors Undergoing Allo-HSCT | NCT04098653 | Allogeneic Hema... Conditioning Myeloid Tumors | Decitabine Busulfan (BU) Cyclophosphamid... | 14 Years - 65 Years | Nanfang Hospital, Southern Medical University | |
| A Two-Step Approach to Bone Marrow Transplant Using Cells From A Partially-Matched Relative | NCT00429143 | Hematologic Mal... | Total Body Irra... Donor Lymphocyt... Cyclophosphamid... Tacrolimus Mycophenolate M... Hematopoietic S... | 18 Years - | Thomas Jefferson University | |
| IDA+BUCY vs BUCY Conditioning Regimen for Intermediate-risk AML Undergoing Auto-HSCT | NCT02671708 | Autologous Hema... Acute Myeloid L... Conditioning | Idarubicin（IDA） Busulfan (BU) Cyclophosphamid... | 14 Years - 65 Years | Nanfang Hospital, Southern Medical University | |
| Decitabine+BUCY vs BUCY Conditioning Regimen for MLL+ Acute Leukemia Undergoing Allo-HSCT | NCT03596892 | Allogeneic Hema... Conditions Mixed-lineage-l... | Decitabine Busulfan (BU) Cyclophosphamid... | 14 Years - 65 Years | Nanfang Hospital, Southern Medical University | |
| G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for Secondary Acute Myeloid Leukemia Undergoing Allo-HSCT | NCT05449899 | Secondary Acute... Allogeneic Hema... Conditioning | Granulocyte Col... Decitabine (DAC... Busulfan (BU) Fludarabine (FL... Cyclophosphamid... | 18 Years - 65 Years | Nanfang Hospital, Southern Medical University | |
| Decitabine + BUCY vs BUCY Conditioning Regimen for TP53+ Myeloid Tumors Undergoing Allo-HSCT | NCT04123392 | TP53 Myeloid Tumors Conditioning Allogeneic Hema... | Decitabine Busulfan (BU) Cyclophosphamid... | 14 Years - 65 Years | Nanfang Hospital, Southern Medical University | |
| Decitabine+BUCY vs BUCY Conditioning Regimen for MLL+ Acute Leukemia Undergoing Allo-HSCT | NCT03596892 | Allogeneic Hema... Conditions Mixed-lineage-l... | Decitabine Busulfan (BU) Cyclophosphamid... | 14 Years - 65 Years | Nanfang Hospital, Southern Medical University | |
| Decitabine + BUCY vs BUCY Conditioning Regimen for TP53+ Myeloid Tumors Undergoing Allo-HSCT | NCT04123392 | TP53 Myeloid Tumors Conditioning Allogeneic Hema... | Decitabine Busulfan (BU) Cyclophosphamid... | 14 Years - 65 Years | Nanfang Hospital, Southern Medical University | |
| BUCYE Conditioning Regimen for PCNSL Undergoing Auto-HSCT | NCT03733327 | Primary Central... Autologous Hema... Conditioning | Busulfan (BU) Cyclophosphamid... Etoposide (VP-1... | 14 Years - 65 Years | Nanfang Hospital, Southern Medical University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
